Mircera (methoxy polyethylene glycol epoetin beta)

Mircera contains the active substance methoxy polyethylene glycol epoetin beta, and is a medicine that stimulates the growth of red blood cells. It is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (CKD) in adult patients. It is given by subcutaneous or intravenous injections, using a pre-filled syringe.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeCovid-19Pharma solutionsRoche careersMedia libraryAnnual Report 2023Privacy policyLegal statement